INTEGER HOLDINGS CORPORATION Other General Expense
INTEGER HOLDINGS CORPORATION (ITGR) reported Other General Expense of $118.00 thousand for the 3-month period ending 2024-03-29, per its 10-Q filed 2024-04-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherGeneralExpense · last filed 2024-04-25
- INTEGER HOLDINGS CORPORATION other general expense for the quarter ending 2024-03-29 was $118.00K, a 42.17% increase year-over-year.
- INTEGER HOLDINGS CORPORATION other general expense for the quarter ending 2023-12-31 was $1.97M, a 3134.43% increase year-over-year.
- INTEGER HOLDINGS CORPORATION other general expense for the quarter ending 2023-09-29 was $28.00K, a 95.53% decline year-over-year.
- INTEGER HOLDINGS CORPORATION other general expense for the quarter ending 2023-06-30 was $26.00K, a 87.32% decline year-over-year.
- INTEGER HOLDINGS CORPORATION other general expense for fiscal 2023 was $2.11M, a 77.61% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION other general expense for fiscal 2022 was $1.19M, a 133.86% increase from fiscal 2021.
- INTEGER HOLDINGS CORPORATION other general expense for fiscal 2021 was $508.00K, a 89.14% decline from fiscal 2020.
- INTEGER HOLDINGS CORPORATION other general expense for fiscal 2020 was $4.68M.
| Period end | Other General Expense 3 month | Other General Expense 6 month | Other General Expense 9 month | Other General Expense 12 month |
|---|---|---|---|---|
| 2024-03-29 | $118.00K 10-Q · filed 2024-04-25 | $2.09M derived: sum of 2 quarters · filed 2024-04-25 | $2.12M derived: sum of 3 quarters · filed 2024-04-25 | $2.15M derived: sum of 4 quarters · filed 2024-04-25 |
| 2023-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $2.00M derived: sum of 2 quarters · filed 2024-02-20 | $2.03M derived: sum of 3 quarters · filed 2024-02-20 | $2.11M 10-K · filed 2024-02-20 |
| 2023-09-29 | $28.00K 10-Q · filed 2023-10-26 | $54.00K derived: sum of 2 quarters · filed 2023-10-26 | $137.00K 10-Q · filed 2023-10-26 | $198.00K derived: sum of 4 quarters · filed 2024-04-25 |
| 2023-06-30 | $26.00K 10-Q · filed 2023-07-27 | $109.00K 10-Q · filed 2023-07-27 | $170.00K derived: sum of 3 quarters · filed 2024-04-25 | $796.00K derived: sum of 4 quarters · filed 2024-04-25 |
| 2023-03-31 | $83.00K 10-Q · filed 2024-04-25 | $144.00K derived: sum of 2 quarters · filed 2024-04-25 | $770.00K derived: sum of 3 quarters · filed 2024-04-25 | $975.00K derived: sum of 4 quarters · filed 2024-04-25 |
| 2022-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $687.00K derived: sum of 2 quarters · filed 2024-02-20 | $892.00K derived: sum of 3 quarters · filed 2024-02-20 | $1.19M 10-K · filed 2024-02-20 |
| 2022-09-30 | $626.00K 10-Q · filed 2023-10-26 | $831.00K derived: sum of 2 quarters · filed 2023-10-26 | $1.13M 10-Q · filed 2023-10-26 | $842.00K derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-07-01 | $205.00K 10-Q · filed 2023-07-27 | $501.00K 10-Q · filed 2023-07-27 | $216.00K derived: sum of 3 quarters · filed 2024-02-20 | $770.00K derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-04-01 | $296.00K 10-Q · filed 2023-04-27 | $11.00K derived: sum of 2 quarters · filed 2024-02-20 | $565.00K derived: sum of 3 quarters · filed 2024-02-20 | $627.00K derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | -$285.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $269.00K derived: sum of 2 quarters · filed 2024-02-20 | $331.00K derived: sum of 3 quarters · filed 2024-02-20 | $508.00K 10-K · filed 2024-02-20 |
| 2021-10-01 | $554.00K 10-Q · filed 2022-10-27 | $616.00K derived: sum of 2 quarters · filed 2022-10-27 | $793.00K 10-Q · filed 2022-10-27 | |
| 2021-07-02 | $62.00K 10-Q · filed 2022-07-28 | $239.00K 10-Q · filed 2022-07-28 | ||
| 2021-04-02 | $177.00K 10-Q · filed 2022-04-28 | |||
| 2020-12-31 | $4.68M 10-K · filed 2023-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |